Walid Chemlali

1.3k citations

19 papers · 665 indexed · h-index 15

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Molecular Biology 11
- RNA modifications and cancer 3
Oncology 9
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 2

Co-authors: Ivan Bièche (17 shared papers)Sophie Vacher (16 shared papers)Didier Meseure (7 shared papers)Céline Callens (6 shared papers)Rosette Lidereau (5 shared papers)Anne Schnitzler (10 shared papers)François Lallemand (4 shared papers)Nicolás André (5 shared papers)
Journals: Oncotarget (5 papers)British Journal of Cancer (3 papers)Molecular Cancer Research (2 papers)Cancers (2 papers)Clinical Cancer Research (1 paper)
Partner nations: France Switzerland Germany

In The Last Decade

Walid Chemlali

19 papers receiving 658 citations

Peers

Countries citing papers authored by Walid Chemlali

Since Specialization

Citations

This map shows the geographic impact of Walid Chemlali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Chemlali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Chemlali more than expected).

Fields of papers citing papers by Walid Chemlali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Chemlali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Chemlali. The network helps show where Walid Chemlali may publish in the future.

Co-authors

The 25 scholars most cited alongside Walid Chemlali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Walid Chemlali Line = papers co-authored together Walid Chemlali links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value Molecular Cancer Research ·Didier Meseure, Sophie Vacher, Kinan Drak Alsibai, Nicolás André, Walid Chemlali, Martial Caly, Rosette Lidereau, Éric Pasmant, Céline Callens, Ivan Bièche	2016	82
2	Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer British Journal of Cancer ·Didier Meseure, Sophie Vacher, François Lallemand, Kinan Drak Alsibai, Rana Hatem, Walid Chemlali, Nicolás André, Leanne de Koning, Éric Pasmant, Céline Callens, Rosette Lidereau, Antonin Morillon, Ivan Bièche	2016	76
3	High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism PLoS ONE ·Sophie Vacher, Patrice Castagnet, Walid Chemlali, François Lallemand, Didier Meseure, Marc Pocard, Ivan Bièche, Martine Perrot‐Applanat	2018	73
4	Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma Clinical Cancer Research ·Luc Cabel, Emmanuelle Jeannot, Ivan Bièche, Sophie Vacher, Céline Callens, Louis Bazire, Adeline Morel, Alice Bernard‐Tessier, Walid Chemlali, Anne Schnitzler, Astrid Lièvre, Joëlle Otz, Mathieu Minsat, Anne Vincent‐Salomon, Jean‐Yves Pierga, Bruno Buecher, Pascale Mariani, Charlotte Proudhon, François‐Clément Bidard, Wulfran Cacheux	2018	65
5	Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer OncoImmunology ·Édith Borcoman, Philippe De La Rochère, Wilfrid Richer, Sophie Vacher, Walid Chemlali, Clémentine Krucker, Nanour Sirab, François Radvanyi, Yves Allory, G. Pignot, N. Barry De Longchamps, Diane Damotte, Didier Meseure, Christine Sedlik, Ivan Bièche, Eliane Piaggio	2019	63
6	ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels British Journal of Cancer ·Sophie Rondeau, Sophie Vacher, Leanne de Koning, Adrien Briaux, Anne Schnitzler, Walid Chemlali, Céline Callens, Rosette Lidereau, Ivan Bièche	2015	44
7	ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas Oncotarget ·Gabrielle Deniziaut, Jean Christophe Tille, François‐Clément Bidard, Sophie Vacher, Anne Schnitzler, Walid Chemlali, Laurence Trémoulet, Laetitia Fuhrmann, Paul Cottu, Roman Rouzier, Ivan Bièche, Anne Vincent‐Salomon	2016	33
8	Loss of the deglutamylase CCP5 perturbs multiple steps of spermatogenesis and leads to male infertility Journal of Cell Science ·Tiziana Giordano, Sudarshan Gadadhar, Satish Bodakuntla, Jonas Straub, Sophie Leboucher, Guillaume Martinez, Walid Chemlali, Christophe Bosc, Annie Andrieux, Ivan Bièche, Christophe Arnoult, Stefan Geimer, Carsten Janke	2019	30
9	Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer Oncology Letters ·Martine Perrot‐Applanat, Sophie Vacher, Cynthia Pimpie, Walid Chemlali, Simon Derieux, Marc Pocard, Ivan Bièche	2019	30
10	Clinical value of R-spondins in triple-negative and metaplastic breast cancers British Journal of Cancer ·Florence Coussy, François Lallemand, Sophie Vacher, Anne Schnitzler, Walid Chemlali, Martial Caly, Nicolás André, Sophie Richon, Didier Meseure, Rania El Botty, Ludmilla DePlater, Laetitia Fuhrmann, Thierry Dubois, Sergio Roman‐Roman, Virginie Dangles‐Marie, Elisabetta Marangoni, Ivan Bièche	2017	28
11	MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways Oncotarget ·Marick Laé, Sophie Gardrat, Sophie Rondeau, Camille Richardot, Martial Caly, Walid Chemlali, Sophie Vacher, Jérôme Couturier, Odette Mariani, Philippe Terrier, Ivan Bièche	2016	26
12	Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609) Journal of Hematology & Oncology ·Liang Xu, Adrien Briaux, Véronique Becette, Camille Benoist, Anaïs Boulai, Walid Chemlali, Anne Schnitzler, Sylvain Baulande, Sofía Rivera, Marie‐Ange Mouret‐Reynier, Laurence Venat‐Bouvet, T. de La Motte Rouge, Jérôme Lemonnier, Florence Lerebours, Céline Callens	2018	23
13	High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL–ARF Bidirectional Promoter Non-Coding RNA ·Kinan Drak Alsibai, Sophie Vacher, Didier Meseure, Nicolás André, Marick Laé, Anne Schnitzler, Walid Chemlali, Jérôme Cros, Élisabeth Longchampt, Wulfran Cacheux, G. Pignot, Céline Callens, Éric Pasmant, Yves Allory, Ivan Bièche	2019	23
14	High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer Molecular Cancer Research ·Simon Garinet, G. Pignot, Sophie Vacher, C. Goux, Anne Schnitzler, Walid Chemlali, Nanor Sirab, Nicolas Barry Delongchamps, Marc Zerbib, Mathilde Sibony, Yves Allory, Diane Damotte, Ivan Bièche	2018	18
15	Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas Oncotarget ·Marie-Paule Sablin, Coraline Dubot, Jerzy Klijanienko, Sophie Vacher, Lamia Ouafi, Walid Chemlali, Martial Caly, Xavier Sastre‐Garau, Emmanuelle Lappartient, Odette Mariani, José Rodriguez, Thomas Jouffroy, Angélique Girod, Valentin Calugaru, Caroline Hoffmann, Rosette Lidereau, Frédérique Berger, Maud Kamal, Ivan Bièche, Christophe Le Tourneau	2016	15
16	Involvement of the FOXO6 transcriptional factor in breast carcinogenesis Oncotarget ·François Lallemand, Ambre Petitalot, Sophie Vacher, Leanne de Koning, Mohammed Taouis, Bernard S. López, Sophie Zinn‐Justin, Nicole Dalla Venezia, Walid Chemlali, Anne Schnitzler, Rosette Lidereau, Ivan Bièche, Sandrine M. Caputo	2017	12
17	Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer Cancers ·Sophie Vacher, Voreak Suybeng, Elodie Girard, Julien Masliah‐Planchon, Grégory Thomson, C. Goux, Simon Garinet, Anne Schnitzler, Walid Chemlali, Virginie Firlej, Diane Damotte, Yves Allory, Maud Kamal, G. Pignot, Ivan Bièche	2020	9
18	Biopathological Significance of PIWI–piRNA Pathway Deregulation in Invasive Breast Carcinomas Cancers ·Didier Meseure, Sophie Vacher, Sabah Boudjemaa, Marick Laé, Nicolás André, Renaud Leclère, Walid Chemlali, Gabriel Champenois, Anne Schnitzler, Laëtitia Lesage, Thierry Dubois, Ivan Bièche	2020	8
19	Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers Oncotarget ·Wilfrid Richer, Julien Masliah‐Planchon, Nathalie Clément, Irène Jiménez, Laetitia Maillot, David Gentien, Benoît Albaud, Walid Chemlali, Christine Galant, Fréderique Larousserie, Pascaline Boudou‐Rouquette, Amaury Leruste, Céline Chauvin, Zhi Yan Han, Jean‐Michel Coindre, Pascale Varlet, Paul Fréneaux, Dominique Ranchère‐Vince, Olivier Delattre, Franck Bourdeaut	2017	7

About Walid Chemlali

Walid Chemlali is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 19 papers that have together received 665 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (4 papers), Cancer-related Molecular Pathways (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer Cells and Metastasis (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (288 citations), Oncology (190 citations), Molecular Biology (363 citations), Biological Psychiatry (13 citations) and Pathology and Forensic Medicine (92 citations). Walid Chemlali has collaborated with scholars based in France, Switzerland and Germany. Frequent co-authors include Ivan Bièche, Sophie Vacher, Didier Meseure, Céline Callens, Rosette Lidereau, Anne Schnitzler, François Lallemand, Nicolás André, Éric Pasmant and Kinan Drak Alsibai. Their work appears in journals such as Oncotarget, British Journal of Cancer, Molecular Cancer Research, Cancers and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact